SUMMARY Greyhound dogs exposed to oral acrylamide for a period of eight weeks developed a sensorimotor peripheral neuropathy that had many features in common with acrylamide neuropathy seen in other species. Most of the animals also developed the clinical and radiological features of megaoesophagus. The association of neuropathy and megaoesophagus suggests that an axonopathy of the vagus may be an aetiological factor in this disorder.
Megaoesophagus occurs spontaneously in the dog and is of uncertain aetiology.1 It has also been produced surgically,2 3 by exposure to the organophosphorus compound di-isopropyl fluorophosphate,4 5 and has been described in a single case of giant axonal neuropathy.6 It is of interest because some characteristics of the canine disorder resemble those seen in human oesophageal motility disturbances.
It was observed during a study of acrylamide neuropathy in the dog that some affected animals developed megaoesophagus. The mechanism of this disturbance has been the subject of the present study. A brief preliminary account has been given. 7 Although acrylamide has been given to many species,8 the effect of the neurotoxin in the dog has been incompletely described.9 In the present study, the clinical effect of acrylamide on the dog is described and contrasted with the illness produced in other species.
Methods
Fourteen greyhounds with an approximate age range of 1 to 5 years were vaccinated against distemper (Combined Distemper Vaccine) and were given a broad spectrum worming agent (oxontel pamoate, 380 mg; pyrantel pamoate, 100 mg). Acrylamide monomer (99 % pure) was dissolved in water at a concentration of 200 mg ml-' and injected into the daily feed. The animals were weighed, examined clinically and given acrylamide orally at a dose of 7 mg kg-' day-1; a pilot study had previously indicated that this dose produced a neuropathy after six to eight weeks. The animals were examined daily and a record was kept of their weight, clinical signs and the accumulated dose of acrylamide.
The oesophagus was examined radiologically in the right lateral position in trained animals that had eaten a mixture of contrast agent (Baritop) and dog food. No restraint was applied to the animals and no premedication was used. Radiology was carried out using a Toshiba 12 pulsed diagnostic X-ray apparatus, (Model KXO-1000). If no contrast material was apparent in the oesophagus and the animals showed no signs of aspiration, 20-25 ml of contrast solution (X-Opaque Powder) were injected into the animal's mouth while in the right lateral position.
Means are expressed with standard deviations, which were all corrected for small numbers. A normal distribution was assumed for all measurements when comparing the normal and acrylamide affected groups. Means were compared using Student's two-tailed t test; probability values less than 0 05 were considered to indicate significance.
The study received ethical approval from the Animal Ethical Review Committee of the Faculty of Medicine, University of Sydney.
Results

Clinicalfeatures
Toe scuffing, which is a sign of early peripheral neuropathy is the sound made as the toenails of the paws hit the ground; it is not present in normal animals. When toe scuffing was heard on two consecutive days the first day was recorded as the time at which the sign became positive. Toe scuffing occurred from 20 
were common to all animals (table 2). There was normal pain sensation and a normal cranial nerve examination. When tested the anal reflex was present. Ataxia was variable in degree. The tone of the forelimb muscles appeared normal in all animals and ataxia localised to the forequarters was not seen. Hindlimb tone was occasionally reduced and all animals showed moderate to severe hindlimb weakness with preservation of proximal power. The patellar reflex was normal in four animals and totally absent in one animal with most being variably reduced.
RADIOLOGICAL FEATURES
Three of the fourteen animals exposed to acrylamide were examined radiologically. The lower thoracic oesophagus in a control greyhound retained very little contrast food mixture. A bolus of contrast agent had a normal tear-drop shape and left a faint coating on the mucosal folds. An acrylamide affected animal (A1l) developed regurgitation after 58 days; 909 the oesophagus appeared atonic and distended with the contrast food mixture. Some contrast material was seen in the stomach (fig 2) .
Another animal (A14) was studied before and after the onset of regurgitation. After 54 days of exposure to acrylamide, there were signs of toe scuffing and ataxia; the eating behaviour was normal and the radiographic examination was normal. Seven days later regurgitation was observed and three days later radiographic examination revealed a dilated oesophagus. Dilatation involved the whole of the intrathoracic portion of the oesophagus, and contrast material was seen in the stomach. At this time muscle weakness and toe folding were present. The radiographic appearance was constant over a period of fifteen minutes and no secondary waves or tertiary contractions were seen on the image intensifier ( fig 3) .
The last animal (A15) was studied frequently during the evolution of peripheral neuropathy. Abnormal feeding behaviour was suspected after 63 A Jl .:
... Sensory impairment was a prominent clinical feature in the dog; it has been reported in man14 but has been difficult to detect in the cat and the primate.8 Toe folding was a reproducible sign in the dog which was consistent with proprioceptive impairment; the ability of the affected animals to stand on the dorsal surface of their hindpaws suggested that there was a marked sensory disturbance in the hindlimb extremities. This predominant sensory impairment in the dog also involved the forelimbs. Pain sensation has remained normal in all species including the dog. 8 Clinical autonomic disturbance is relatively common in man12 although rare in animals exposed to acrylamide. The presence of normal sexual function suggested that the dog did not have clinical autonomic dysfunction. Although voice change was not noticed in the dog it has been reported in the cat and baboon.8 Weight loss was a consistent feature of all dogs exposed to acrylamide and has also been described in man and primates. In baboons, weight loss occurs despite gastric tube feeding.1' Dogs lost weight despite a good appetite and unlimited food.
The susceptibility of dogs and cats to acrylamide is similar and both species develop similar neurological deficits. The primate seems less sensitive to the neurotoxic action of acrylamide but this may reflect the different eating habits of primates compared with dogs. Acrylamide administration produced a peripheral neuropathy in the dog that is very similar clinically to the neuropathy reported in all other species exposed to the neurotoxin.
MEGAOESOPHAGUS AND NEUROPATHY
While the peripheral neuropathy in the dog exposed to acrylamide was similar to that described in other species, the feeding disturbance reported in the present study has not been seen in other animals or man exposed to this neurotoxin. Monkeys have difficulty in chewing food when there is severe neuropathy15 but this is quite distinct from the feeding disorder seen in the dog. The association of neuropathy and megaoesophagus was observed clinically in nine out of fourteen animals. Four of the five animals that retained normal eating behaviour were not given acrylamide after the appearance of marked sensory impairment of the hindpaws; it was likely that continued neurotoxin administration would have resulted in regurgitation due to megaoesophagus. In the present study the association of megaoesophagus and neuropathy seemed a strong one; virtually all the previous reports of megaoesophagus in adult dogs fail to mention any neurological abnormality.' 1617 As it is unlikely that the degree of neuropathy described in the present study could be missed in so many clinical descriptions it would seem probable that canine megaoesophagus can result from a number of pathological processes.
Organophosphorus compounds and acrylamide produce peripheral neuropathies with very similar clinical features although there are ultrastructural differences in the degenerative changes seen in axons.17 19 When dogs have been exposed to diisopropyl fluorophosphate they develop oesophageal dilatation.45 Although the presence of neuropathy was not discussed or proven in these animals5 hindquarter weakness was described. It is probable that acrylamide and organophosphorus compounds, which both cause an axonopathy affecting the largest diameter nerve fibres produce a similar clinical picture of sensorimotor neuropathy and megaoesophagus in the dog.
The clinical association of neuropathy and megaoesophagus has been described in an Alsatian dog with naturally occurring giant axonal neuropathy.6 Ultrastructural studies revealed enlarged axons swollen with neurofilaments. Similarly an ultrastructural characteristic of acrylamide damage in other species has been the accumulation of neurofilaments in axons.19 8 The clinical features of naturally occurring and artificially induced megaoesophagus were identical.' 16 17 Since all the dogs that were exposed to acrylamide were adult and were not recently weaned, the clinical features of megaoesophagus in the present study more closely resembled the naturally occurring disease in the older animal. The presence of megaoesophagus was confirmed radiologically. This has been the standard method for establishing the presence of oesophageal dilatation.'7 20 The radiological features of oesophageal dilatation in the present study mimicked those described in naturally occurring megaoesophagus,"1617 20 although the degree of dilatation did not match the gross sac-like enlargements occasionally reported in the spontaneous disorder.2 ' A pathological process that has been suggested as a cause of naturally occurring canine megaoesopha-gus is dysfunctioni of the neuromuscular control of the oesophagus.22-24 Although vagal abnormalities could not be demonstrated in animals with naturally occurring megaoesophagus,2" the association of megaoesophagus and acrylamide administration in the present study emphasises the importance of degenerative changes in the neural innervation of the oesophagus in this disorder; acrylamide has no direct effect on skeletal or smooth muscle.8 The consistent feature of acrylamide neuropathy has been the greater degree of functional changes in sensory nerves that occur before changes in motor nerves.25Thus it can be suggested that in those cases of canine megaoesophagus which can be attributed to dysfunction of the neural innervation, the site of functional disturbance is more likely to be in the sensory innervation of the oesophagus.
Acrylamide megaoesophagus is easy to produce and is quite reproducible. It offers a unique opportunity to study an oesophageal motility disorder as it evolves. While oesophageal abnormalities have not been described in other species exposed to acrylamide there are structural and functional differences of the canine oesophagus which could account for the vulnerability of this organ when dogs suffer a sensorimotor peripheral neuropathy. The stimulus for oesophageal peristalsis produced by an intraluminal bolus differs according to its site and the animal species.26 In species with a predominantly striated muscle oesophagus it is only the dog that has an absolute requirement for the presence of a bolus in the cervical oesophagus.27 These observations provide indirect evidence that megaoesophagus in the dog exposed to acrylamide is due to damage to vagal afferent nerve fibres. 
